Nutritional changes and micronutrient supply in patients with phenylketonuria under therapy with tetrahydrobiopterin (BH4)

JIMD Reports

Volumn 9, Issue , 2013, Pages 31-40

  Thiele, A G ^c   Weigel, J F ^a   Ziesch, B ^a   Rohde, C ^a   Mutze U ^a   Ceglarek, U ^b   Thiery, J ^b   Muller A S ^c   Kiess, W ^a   Beblo, S ^a  

^a UNIVERSITY HOSPITAL LEIPZIG   (Germany)

^b UNIVERSITY OF LEIPZIG   (Germany)

^c MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84891849836     PISSN: 21928304     EISSN: 21928312     Source Type: Book Series    
DOI: 10.1007/8904_2012_176     Document Type: Chapter

References (35)

1. Blau N, Bélanger-Quintana A, Demirkol M, Feillet F, Giovannini M, Mac Donald A, Trefz FK, van Spronson FJ (2009) Optimizing the use of sapropterin (BH4) in the management of phenylketonuria. Mol Genet Metab 96:158–163
2. Blau N, Hennermann JB, Langenbeck U, Lichter-Konecki U (2011) Diagnosis, classification, and genetics of phenylketonuria and tetrahydrobiopterin (BH4) deficiencies. Mol Genet Metab 104 (Suppl):S2–S9
3. Bélanger-Quintana A, García MJ, Castro M, Desviat LR, Pérez B, Mejía B et al (2005) Spanish BH4-responsive phenylalanine hydroxylase-deficient patients: evolution of seven patients on long-term treatment with tetrahydrobiopterin. Mol Genet Metab 86(Suppl 1):S61–S66
4. Burgard P, Rey F, Rupp A, Abadie V, Rey J (1997) Neuropsychologic functions of early treated patients with phenylketonuria, on and off diet: results of a cross-national and cross-sectional study. Pediatr Res 41:368–374
5. Burlina A, Blau N (2009) Effect of BH(4) supplementation on phenylalanine tolerance. J Inherit Metab Dis 32:40–45
6. Burton BK, Grange DK, Milanowski A, Vockley G, Feillet F, Crombez EA et al (2007) The response of patients with phenylketonuria and elevated serum phenylalanine to treatment with oral sapropterin dihydrochloride (6R-tetrahydrobiopterin): a phase II, multicentre, open-label, screening study. J Inherit Metab Dis 30:700–707
7. Burton BK, Bausell H, Katz R, Laduca H, Sullivan C (2010) Sapropterin therapy increases stability of blood phenylalanine levels in patients with BH4-responsive phenylketonuria (PKU). Mol Genet Metab 101:110–114
8. Ceglarek U, Muller P, Stach B, Buhrdel P, Thiery J, Kiess W (2002) Validation of the phenylalanine/tyrosine ratio determined by tandem mass spectrometry: sensitive newborn screening for phenylketonuria. Clin Chem Lab Med 40:693–697
9. De Bourdeaudhuij I, te Velde S, Brug J, Due P, Wind M, Sandvik C et al (2008) Personal, social and environmental predictors of daily fruit and vegetable intake in 11-year-old children in nine European countries. Eur J Clin Nutr 62:834–841
10. Elfhag K, Tholin S, Rasmussen F (2008) Consumption of fruit, vegetables, sweets and soft drinks are associated with psychological dimensions of eating behaviour in parents and their 12-year-old children. Public Health Nutrition 11:914–923
11. Fiori L, Fiege B, Riva E, Giovannini M (2005) Incidence of BH4-responsiveness in phenylalanine-hydroxylase-deficient Italian patients. Mol Genet Metab 86(Suppl 1):S67–S74
12. Germany (D), Austrian (A), Swiss (CH)DACH-Reference values for the intake of nutritive substances (Referenzwerte fur die Nahrstoffzufuhr, DGE 2000) Deutsche Gesellschaft fur Ernahrung e.V. (DGE), Österreichische Gesellschaft fur Ernahrung (ÖGE), die Schweizerische Gesellschaft fur Ernahrungsforschung SGE, Schweizerische Vereinigung fur Ernahrung: Referenzwerte fur die Nahrstoffzufuhr (Germany, [DACH, 2000] 1st ed Frankfurt am Main, Umschau/ Braus 2000
13. Hartmann B (2009) Bundeslebensmittelschluessel. Max-Rubner-Institut, Karlsruhe, Germany. http://www.bls.nvs2.de/index.php?id¼37
14. Hennermann JB, Buhrer C, Blau N, Vetter B, Monch E (2005) Long-term treatment with tetrahydrobiopterin increases phenylalanine tolerance in children with severe phenotype of phenylketonuria. Mol Genet Metab 86(Suppl 1):S86–S90
15. Kaufman S, Berlow S, SUmmer GK, Milstien S, Schulman JD, Orloff S, Spielberg S, Pueschel S (1978) Hyperphenylalaninemia due to a deficiency of biopterin: a variant form of phenylketonuria. N Engl J Med 299:673–679
16. Kersting M, Alexy U (2005) iX—Empfehlungen fur die Ernahrung von Kindern und Jugendlichen (German). aid Infodienst, Bonn
17. Kremers SP, Brug J, de Vries H, Engels RC (2003) Parenting style and adolescent fruit consumption. Appetite 41:43–50
18. Lambruschini N, Pérez-Dueñas B, Vilaseca MA, Mas A, Artuch R, Gassió R et al (2005) Clinical and nutritional evaluation of phenylketonuric patients on tetrahydrobiopterin monotherapy. Mol Genet Metab 86(Suppl 1):S54–S60
19. Macdonald A (2000) Diet and compliance in phenylketonuria. Eur J Pediatr 159(Suppl 2):S136–S141
20. Macdonald A, Rylance G, Davis P, Asplin D, Hall SK, Booth IW (2003) Free use of fruits and vegetables in phenylketonuria. J Inherit Metab Dis 26:327–338
21. Macdonald A, Gokmen-Ozel H, van Rijn M, Burgard P (2010) The reality of dietary compliance in the management of phenylketonuria. J Inherit Metab Dis 33:665–670
22. Mensink GBM, Heseker H, Richter A et al (2007) Ernahrungsstudie als KiGGS-Modul (EsKiMo). Forschungsbericht. RKI, Univer-sitatPaderborn, Berlin, Paderborn
23. Mutze U, Roth A, Weigel JF et al (2011) Transition of young adults with phenylketonuria from pediatric to adult care. J Inherit Metab Dis 34(3):701–709
24. Muntau AC, Roschinger W, Habich M et al (2002) Tetrahydrobiopterin as an alternative treatment for mild phenylketonuria. N Engl J Med 347:2122–2132
25. Rohde C, Mutze U, Weigel J FK, Ceglarek U, Thiery J, Kiess W, Beblo S (2012) Unrestricted consumption of fruits and vegetables in phenylketonuria: no major impact on metabolic control. Eur J Clin Nutr. http://www.nature.com/ejcn/journal/vaop/ncurrent/full/ejcn2011205a.html
26. Schulz B, Bremer HJ (1995) Nutrient intake and food consumtion of adolescents and young adults with phenylketonuria. Acta Paediatr 84:743–748
27. Scriver CR, Kaufman S, Eisensmith RC, Woo SLC (1998) The hyperphenylalaninemias. In: Scriver RC, Beaudet AL, Sly WS, Valle D (eds) The metabolic and molecular basis of inherited disease. McGraw-Hill, New York, pp 1015–1075
28. Singh RH, Quirk ME, Douglas TD, Brauchla MC (2010) BH(4) therapy impacts the nutrition status and intakeinchildrenwithphenylke-tonuria: 2-year follow-up. J Inherit Metab Dis 33:689–696
29. Stemerdink BA, Kalverboer AF, van der Meere JJ et al (2000) Behaviour and school achievement in patients with early and continuously treated phenylketonuria. J Inher Metab Dis 23:548–562
30. Trefz FK, Burton BK, Longo N et al (2009) Efficacy of sapropterin dihydrochloride in increasing phenylalanine tolerance in children with phenylketonuria: a phase III, randomized, double-blind, placebo-controlled study. J Pediatr 154:700–707
31. Unuvar T, Buyukgebiz A (2010) Nutritional rickets and vitamin D deficiency in infants, children and adolescents. Pediatr Endocrinol Rev 7:283–291
32. Weglage J, Funders B, Wilken B et al (1992) Psychological and social findings in adolescents with phenylketonuria. Eur J Pediatr 151:522–525
33. Zabinski MF, Daly T, Norman GJ, Rupp JW, Calfas KJ, Sallis JF et al (2006) Psychosocial correlates of fruit, vegetable, and dietary fat intake among adolescent boys and girls. J Am Diet Assoc 106:814–821
34. 4) in PKU: effect on dietary treatment, metabolic control and quality of life. J Inher Metab Dis. doi:10.1007/s10545-012-9458-1
35. Zimmermann M, Jacobs P, Fingerhut R, Torresani T, Thony B, Blau N, Baumgartner MR, Rohrbach M (2012) Positive effect of a simplified diet on blood phenylalanine control in different phenylketonuria variants, characterized by newborn BH4 loading test and PAH analysis. Mol Genet Metab 106:264–268